GI
DFTX

GAMMA Investing’s Definium Therapeutics DFTX Stock Holding History

GAMMA Investing’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57K Buy
1,212
+101
+9% +$2.5K ﹤0.01% 2217
2026
Q1 		$21K Buy
1,111
+81
+8% +$1.38K ﹤0.01% 2689
2025
Q4 		$13.8K Buy
1,030
+111
+12% +$1.37K ﹤0.01% 2819
2025
Q3 		$10.8K Sell
919
-189
-17% -$1.76K ﹤0.01% 2843
2025
Q2 		$7.19K Buy
1,108
+415
+60% +$2.73K ﹤0.01% 2970
2025
Q1 		$4.05K Buy
693
+587
+554% +$4.2K ﹤0.01% 3166
2024
Q4 		$738 Sell
106
-77
-42% -$530 ﹤0.01% 3504
2024
Q3 		$1.04K Buy
+183
New +$1.27K ﹤0.01% 3243

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's DFTX Position: Q2 2026 in Review

GAMMA Investing increased its Definium Therapeutics (DFTX) stake by 9.1% in Q2 2026, buying an estimated $2.5K and bringing the position to 1,212 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

GAMMA Investing first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 17 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • GAMMA Investing held 1,212 shares of Definium Therapeutics worth $57K as of Q2 2026.
  • GAMMA Investing bought 101 Definium Therapeutics shares in Q2 2026, an estimated $2.5K.
  • Definium Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2217 holding.
  • GAMMA Investing first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 17 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.